Description
The antibody is a Human IgG1, kappa targets SARS-CoV-2 (2019-nCoV) RBD (Omicron/JN.1)
Target
RBD (Omicron/JN.1)
Target Alias Names
Spike glycoprotein, S glycoprotein, Spike protein S1, Receptor-Binding Domain, RBD, JN.1, SARS-CoV-2 (2019-nCoV)
Isotypes/Mimetics
IgG1, kappa
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
Unknown
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression